Last reviewed · How we verify

NCT04024826

Effects of Resistance Training on Substrate Metabolism During the Menstrual Cycle

Terminated NA Last updated 4 October 2021
What this trial tests

NA trial testing EFP in Menstrual Cycle in 10 participants. Terminated before completion.

Timeline
1 July 2019
Primary endpoint
16 March 2020
16 March 2020

Quick facts

Lead sponsorSouthern Illinois University Edwardsville
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment10
Start date1 July 2019
Primary completion16 March 2020
Estimated completion16 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Southern Illinois University Edwardsville

Who can join

Adults 18 to 45, female only, with Menstrual Cycle or Substrate Metabolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research project's objective is to investigate substrate metabolism behavior in response to the RT during different phases of the menstrual cycle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of EFP

Trials testing the same drug.

Other recruiting trials for Menstrual Cycle

Currently open trials in the same condition.

Other Southern Illinois University Edwardsville trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04024826.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing